SCHEMBL5077938

SCHEMBL5077938

C=C(CC=CCCCC)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F7 P08709 3/20 0.50
F3 P13726 3/20 0.50
FNTA P49354 1/20 0.46
FNTB P49356 1/20 0.46
PPARG P37231 6/20 0.46
PPARD Q03181 5/20 0.46
PPARA Q07869 5/20 0.46
TERT O14746 3/20 0.46
PTPN1 P18031 3/20 0.46
MAPT P10636 3/20 0.46
BLM P54132 3/20 0.46
HSD17B10 Q99714 3/20 0.46
FABP4 P15090 3/20 0.46
TOP1 P11387 3/20 0.46
USP2 O75604 2/20 0.46
LMNA P02545 2/20 0.46
ALOX15 P16050 2/20 0.46
RECQL P46063 2/20 0.46
CYP19A1 P11511 2/20 0.46
PTGS1 P23219 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5074700 0.94 PPARG (0.53) F7F3FNTAFNTBPPARG
SCHEMBL355323 0.92 TERT (0.56) F7F3FNTAFNTBPPARG
SCHEMBL5429083 0.92 TERT (0.56) F7F3FNTAFNTBPPARG
SCHEMBL449495 0.92 TERT (0.56) F7F3FNTAFNTBPPARG
SCHEMBL447306 0.92 TERT (0.56) F7F3FNTAFNTBPPARG
SCHEMBL449780 0.92 TERT (0.56) F7F3FNTAFNTBPPARG
SCHEMBL446813 0.92 TERT (0.56) F7F3FNTAFNTBPPARG
SCHEMBL450907 0.92 TERT (0.56) F7F3FNTAFNTBPPARG
SCHEMBL447706 0.92 TERT (0.56) F7F3FNTAFNTBPPARG
SCHEMBL746539 0.92 TERT (0.56) F7F3FNTAFNTBPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074576-B1 Method for preparing crosslinked organic particles and suspensions DOW CORNING TORAY CO LTD (JP) 2008-05-14 EP claimed
EP-0013073-B1 CROSS LINKABLE BLENDS WITH IONIZING RADIATIONS OF P-METHYLSTYRENE POLYMER WITH A POLYUNSATURATED MONOMER AND SHAPED ARTICLES FORMED THEREFROM MOBIL OIL CORPORATION (US) 1982-09-22 EP claimed
US-9803114-B2 Acrylic adhesive composition with controlled molecular weight 3M INNOVATIVE PROPERTIES COMPANY (US) 2017-10-31 US disclosed
US-20120301525-A1 SILICONE OIL EMULSION, METHOD OF PRODUCING SAME, AND SILICONE OIL COMPOSITION DOW CORNING TORAY CO., LTD. (JP) 2012-11-29 US disclosed
US-6461597-B1 CROSSLINKED SILICONE PARTICLES CONTAINED IN DROPS OF SILICONE OIL DOW CORNING TORAY SILICONE CO., LTD. (JP) 2002-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120301525-A1 SILICONE OIL EMULSION, METHOD OF PRODUCING SAME, AND SILICONE OIL COMPOSITION SQLE, SRM, SOAT2 F7 1938/4885F3 3049/4885FNTA 1465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.